Rad53 Antibodies

Santa Cruz Biotechnology provides a broad selection of Rad53 monoclonal antibodies for research in cell cycle regulation and DNA damage response. Rad53 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rad53, a key protein in the DNA damage checkpoint pathway, plays a crucial role in maintaining genomic stability by coordinating cell cycle arrest and DNA repair mechanisms. The function of Rad53 is vital for preventing the propagation of damaged DNA, which can lead to tumorigenesis. Understanding Rad53 activity is essential for elucidating the molecular mechanisms underlying cancer and other diseases related to DNA damage. Rad53 research continues to reveal new insights into cellular responses to DNA damage and checkpoint regulation. Investigating Rad53 pathways helps scientists better understand how cells maintain genomic integrity. The development of targeted therapies for DNA damage-related diseases benefits from ongoing Rad53 research. Santa Cruz Biotechnology monoclonal antibodies for Rad53 support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.